MedMira Announces Product Update
HALIFAX, Nova Scotia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its
Read moreCA58501R1029
MedMira Reports First Quarter Results FY2021
HALIFAX, Nova Scotia, Dec. 24, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results
Read moreMedMira Reports FY2020 Fourth Quarter and Year End Financial Results
HALIFAX, Nova Scotia, Nov. 30, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results
Read moreMedMira reports additional independent performance evaluation results of REVEALCOVID-19™ Total Antibody Test
HALIFAX, Nova Scotia, Oct. 07, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the
Read moreMedMira reports additional independent performance evaluation results of REVEALCOVID-19™ Total Antibody Test
HALIFAX, Nova Scotia, Oct. 07, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the
Read moreMedMira reports additional independent performance evaluation results of REVEALCOVID-19™ Total Antibody Test
HALIFAX, Nova Scotia, Oct. 07, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the
Read moreREVEALCOVID-19™ Total Antibody Test Sensitivity and Cross-Reactivity Analysis
HALIFAX, Nova Scotia, Sept. 03, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) reports findings to further emphasize
Read moreMedMira’s July Update as per the IIROC Request
HALIFAX, Nova Scotia, July 10, 2020 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) would like to issue a
Read more
MedMira Announces Progress Update of its REVEALCOVID-19™ Total Antibody Test Including CE Mark
MedMira has completed the registration process and affixed the CE mark to its rapid REVEALCOVID-19 Total Antibody Test.
Read more